August 24, 2022

Clinical Outcomes Of Euglycemic Diabetic Ketoacidosis (euDKA) Treated With a Computerized Insulin Algorithm: Descriptive Analysis of a Nationwide Cohort

In Research Study by Alexa Driscoll

In this largest descriptive analysis of a nationwide cohort in the United States shows that euDKA can be safely and effectively treated with a computerized algorithm in the hospital, as patients achieved rapid time to target, rapid resolutionofDKA, and a lowmortality rate.

June 25, 2021

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools

In by Alexa Driscoll

IV Insulin via Glucommander, eGlycemic Management System (eGMS), Demonstrates Low Rates of Hypoglycemia in Patients with Low eGFR Compared to Other Electronic Glycemic Management Tools Presentation ADA Virtual 81st Scientific Sessions Date June 25, 2021 Authors Bruce Bode, MD, FACE¹, John Clarke, RN, CDCES², Jordan Messler, MD, SFHM, FACP², Robert Booth, CPHQ² AUTHOR AFFILIATIONS ¹Atlanta Diabetes Associates, Atlanta, GA, USA, …

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA

In by Alexa Driscoll

Glycemic Outcomes for Adult Type 1 Diabetes (T1D) With and Without DKA Presentation ADA Virtual 81st Scientific Sessions Date June 25, 2020 Authors Jordan Messler, MD, SFHM, FACP¹, Priyathama Vellanki, MD², Bruce Bode, MD, FACE³, John Clarke RN, CDCES¹, Robert Booth, CPHQ¹ Author Affiliations ¹Glytec, Waltham, MA, USA, ²Emory University School of Medicine, Atlanta, GA, USA, ³Atlanta Diabetes Associates, Atlanta, …

June 13, 2020

Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes using Continuous Glucose Monitoring

In by Alexa Driscoll

Evaluating the Impact of Glucommander on Improvement in Time-in-Range (TIR) in Type 2 Diabetes using Continuous Glucose Monitoring Presentation ADA Virtual 80th Scientific Sessions Date June 13, 2020 Authors Bruce Bode, MD, FACE, John Clarke, RN, CDES PURPOSE An IRB-approved proof-of-concept single-center prospective study to evaluate the safety and efficacy of utilizing Glucommander outpatient insulin dosing software to assist providers …

June 9, 2019

Comparison of Hyperglycemia Management Protocols in the ICU: Standard Protocol versus eGlycemic Management System

In by Heather DelCarpini

Comparison of Hyperglycemia Management Protocols in the ICU: Standard Protocol versus eGlycemic Management System Presentation American Diabetes Association Scientific Sessions Date June 2019 Authors Jordan Messler,1 Guillermo Umpierrez2 BACKGROUND A variety of continuous insulin infusion (CII) algorithms are available to improve and maintain glycemic control in the ICU. American Diabetes Association guidelines state that: (a) insulin therapy should be initiated …

June 11, 2017

Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System

In by Heather DelCarpini

Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System Reduction in Hypoglycemic Events: 2,434 fewer hypoglycemic events with GM versus UC, resulting in savings of $7,141,356 over the first year, or $2,934 per event. Reduction in Average Length of Stay: 1.67 fewer days, resulting in savings over the …

June 12, 2016

A Comparison of Glycemic Outcomes for Two Computerized Insulin Infusion Algorithms in CV Surgery Patients

In by Heather DelCarpini

A Comparison of Glycemic Outcomes for Two Computerized Insulin Infusion Algorithms in CV Surgery Patients Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors Valerie Garrett,1 Linda Fornoff,1 Jodie Becker,1 Raymie McFarland,2 Robby Booth,2 Amy Henderson2 BACKGROUND Hyperglycemia in patients undergoing cardiovascular (CV) surgery is an independent risk factor for increased morbidity and mortality. Studies have shown that optimal …

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points

In by Heather DelCarpini

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors John Clarke, Bruce Bode, Robby Booth, Harry Hebblewhite BACKGROUND Treatment of diabetes with multiple daily injections, using a regimen of basal and rapid-acting insulins is widely accepted as the standard of care. …

Selecting the Initial Multiplier and Target Glucose of a Computer-Guided Insulin Delivery System (Glucommander) During Treatment of Diabetic Ketoacidosis

In by Heather DelCarpini

Selecting the Initial Multiplier and Target Glucose of a Computer-Guided Insulin Delivery System (Glucommander) During Treatment of Diabetic Ketoacidosis Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors David Reyes-Umpierrez,1 Francisco Pasquel,1 Raymie McFarland,2 Robby Booth,2 Bruce Bode,3 Guillermo Umpierrez1 Introduction A variety of computer-based algorithms to direct nursing staff adjusting insulin infusion rate are commercially available for the …

Sepsis-Related Dysglycemia Can a Computerized IV Insulin Algorithm Improve Glycemic Control, Reduce Hypoglycemia and Reduce 30-Day Hospital Readmissions?

In by Heather DelCarpini

Sepsis-Related Dysglycemia: Can a Computerized IV Insulin Algorithm Improve Glycemic Control, Reduce Hypoglycemia and Reduce 30-Day Hospital Readmissions? Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors Joseph Aloi,1 Raymie McFarland,2 Robby Booth,2 Amy Henderson2 BACKGROUND Dysglycemia has been shown to have a negative impact on patient outcomes including readmissions. Many acute illnesses can result in stress hyperglycemia, even …

The Frequency of Hypoglycemia in Hospitalized Patients Treated With Insulin Increases Overall Costs Associated with Hospitalization and Length of Stay

In by Heather DelCarpini

The Frequency of Hypoglycemia in Hospitalized Patients Treated With Insulin Increases Overall Costs Associated with Hospitalization and Length of Stay Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors Joseph Aloi,1 Jagdeesh Ullal,2 Amy Henderson,3 Raymie McFarland3 BACKGROUND Hyperglycemia during hospitalization is associated with poor patient outcomes, as well as increased costs, due to impact on length of stay, …

June 7, 2015

eGlycemic Management System Safely Achieves Rapid and Sustained Glycemic Control in Kidney Transplant Patients and Reduces Risk of Hypoglycemia Compared to Standard Treatment Protocols

In by Heather DelCarpini

eGlycemic Management System Safely Achieves Rapid and Sustained Glycemic Control in Kidney Transplant Patients and Reduces Risk of Hypoglycemia Compared to Standard Treatment Protocols Presentation American Diabetes Association Scientific Sessions Date June 2015 Authors Joseph Aloi,1 Raymie McFarland,2 Jadeesh Ullal,3 Melanie Mabrey,2,4 Kathy Price Ward3 Objective Management of patients with steroid-induced hyperglycemia can be difficult. Intravenous insulin infusions are generally …

Finding the Sweet Spot in Bone Marrow Transplant Patients Computer Guided Glucose Management System in Allogeneic Hematopoietic Cell Transplant Recipients

In by Heather DelCarpini

Finding the Sweet Spot in Bone Marrow Transplant Patients: Computer Guided Glucose Management System in Allogeneic Hematopoietic Cell Transplant Recipients Presentation American Diabetes Association Scientific Sessions Date June 2015 Authors Cora Espina, Lenise Taylor, Rafic Farah, Eunipi Cho, Joshua Epworth, Lori Jarrett, Ted Gooley, Paul O’Donnell, Irl Hirsch, Merav Bar Background Allogeneic hematopoietic cell transplantation (HCT) is the only potential …

Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes

In by Heather DelCarpini

Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes Presentation American Diabetes Association Scientific Sessions Date June 2015 Authors Joseph Aloi,1 Robby Booth,2 Raymie McFarland,2 Jagdeesh Ullal,3 Melanie Mabrey2 Objective Hyperglycemia, regardless of its cause, is clearly associated with adverse outcomes in hospitalized patients. Hyperglycemia in patients with no known history …

June 6, 2015

Patients With Kidney Disease Reach Target Glucose With Low Incidence of Hypoglycemia When IV Insulin Is Managed on eGlycemic Management System Glucommander

In by Heather DelCarpini

Patients With Kidney Disease Reach Target Glucose With Low Incidence of Hypoglycemia When IV Insulin Is Managed on eGlycemic Management System Glucommander Presentation American Diabetes Association Scientific Sessions Date June 2015 Authors Joe Aloi,1 Raymie McFarland,2 Robby Booth,2 Melanie Mabrey,2 Paul Chidester,3 Amy Henderson,2 Andrew Rhinehart2 Objective Glucose control in hospitalized patients with kidney disease can be challenging. The impact …

June 15, 2014

Sentara Health System Sees Glycemic Improvement for Hospital Basal Bolus Patients in the First 30 Days Using eGlycemic Management System by Glytec

In by Heather DelCarpini

Sentara Health System Sees Glycemic Improvement for Hospital Basal Bolus Patients in the First 30 Days Using eGlycemic Management System by Glytec Presentation American Association of Clinical Endocrinologists Scientific & Clinical Congress American Diabetes Association Scientific Sessions Date May 2014 June 2014 Authors Joseph Aloi,1 Paul Chidester,2 Raymie McFarland3 Objective Hospitalized patients who experience hyper/hypoglycemia have been associated with increased …

Hospitalization Costs, Resource Utilization, and Clinical Outcome in Patients Undergoing CABG Receiving Intensive Versus Conservative Glucose Control

In by Heather DelCarpini

Hospitalization Costs, Resource Utilization, and Clinical Outcome in Patients Undergoing CABG Receiving Intensive Versus Conservative Glucose Control Presentation American Diabetes Association Scientific Sessions Date June 2014 Authors D Smiley,1 S Cardona,1 J Weaver,2 K Register,2 L Peng,3 F Pasquel,1 G Umpierrez1 Background It is estimated that 50-90% of patients undergoing coronary artery bypass (CABG) develop hyperglycemia during the hospital course …

Mountain States Health Alliance Achieves Dramatic Improvements in Glycemic Control With The eGlycemic Management System By Glytec

In by Heather DelCarpini

Mountain States Health Alliance Achieves Dramatic Improvements in Glycemic Control With The eGlycemic Management System By Glytec Presentation American Diabetes Association Scientific Sessions Date June 2014 Authors Raymie McFarland,1 Tamera Parsons,2 Randall Ball,2 Amy Henderson,1 Andrew Rhinehart2 Objective In the last few years, there has been an increased awareness of the importance of inpatient glycemic management and its connection to …

Sentara Health System Prepares for VBP Measure Changes With SCIP Inf-4 by Turning to Patient Centric IV Insulin Dosing Software

In by Heather DelCarpini

Sentara Health System Prepares for VBP Measure Changes With SCIP Inf-4 by Turning to Patient Centric IV Insulin Dosing Software Presentation American Diabetes Association Scientific Sessions Date June 2014 Authors Raymie McFarland, Paul Chidester, Joseph Aloi, Stephanie Conner, Susan Schriever Abstract Hyperglycemic control has long been associated with improved in-hospital mortality and morbidity in the cardiac surgical population. Successful experience …

June 26, 2010

A Computerized Intravenous Insulin Controller (CIIC) Shows Significantly Less Hypoglycemia Than NICE-SUGAR and Eight Paper Protocols for Intensive Control – 0.3% vs. 12.6%

In by Heather DelCarpini

A Computerized Intravenous Insulin Controller (CIIC) Shows Significantly Less Hypoglycemia Than NICE-SUGAR and Eight Paper Protocols for Intensive Control – 0.3% vs. 12.6% Presentation International Hospital Diabetes Meeting American Diabetes Association Scientific Sessions Date May 2010 June 2010 Authors Paul Davidson, R Dennis Steed, Bruce Bode, Harry Hebblewhite Abstract The optimal target BG range for critically ill patients is controversial. …